TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
Aim. To study the influence of metabolic cytoprotector trimetazidine on the heart rate variability (HRV) in patients with stable ischemic heart disease (CHD).Material and methods. Into the simple, prospective, non-randomized trial totally 50 patients included with stable CHD, continuously showed pos...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2014-10-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/53 |